Fas Antigen (CD95) and Hematopoietic Progenitor Cells

References

• Kerr J. F. R., Wyllie A. H., Currie A. R. Apoptosis; A basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239
   PubMed Web of Science ®Google Scholar
• Wyllie A. H., Kerr J. F. R., Currie A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 1980; 68: 251
   PubMedGoogle Scholar
• Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989; 169: 1747
   PubMed Web of Science ®Google Scholar
• Trauth B. C., Klas C., Peters A. M. J., Matzku S., Moeller P., Falk W., Debatin K. M., Krammer P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301
   PubMed Web of Science ®Google Scholar
• Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233
   PubMed Web of Science ®Google Scholar
• Ito N., Nagata S. A novel protein domain required for apoptosis. J. Biol. Chem. 1993; 268: 10932
   PubMed Web of Science ®Google Scholar
• Tartaglia L. A., Ayers T. M., Wong G. H. W., Goeddel D. V. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74: 845
   PubMed Web of Science ®Google Scholar
• Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169
   PubMed Web of Science ®Google Scholar
• Takahashi T., Tanaka M., Inazawa J., Abe T., Suda T., Nagata S. Human Fas ligand: gene struture, chromosomal location and species specificity. Int. Immunol. 1994; 6: 1567
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R., Brannan C. I., Ito N., Yonehara S., Copeland N. G., Jenkins N. A., Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 1992; 148: 1274
   PubMed Web of Science ®Google Scholar
• Kobayashi N., Hamamoto Y., Yamamoto N., Ishii A., Yonehara N., Yonehara S. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA 1990; 87: 9620
   PubMed Web of Science ®Google Scholar
• Falk M. H., Trath B. C., Debatin K. M., Klas C., Gregory C. D., Rickman A. B., Calender A., Lenoir G. M., Ellwart J. W., Krammer P. H., Bornkamm G. W. Expression of Apo-1 antigen in Burkitt lymphoma cell lines correlates with a shift toward a lymphoblastoid phenotype. Blood 1992; 79: 3300
   PubMed Web of Science ®Google Scholar
• Debtain K. M., Goldman C. K., Waldmann T. A., Krammer P. H. Apo-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 1993; 81: 2972
   PubMed Web of Science ®Google Scholar
• Moeller P., Henne C., Leithhaeuser F., Eichelmann A., Schmidt A., Bruederlein S., Dhein J., Krammer P. H. Coregulation of the Apo-1 antigen wtih intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphoma. Blood 1993; 81: 2067
   PubMed Web of Science ®Google Scholar
• Vigunaux F., Vivier E., Malissen B., Depraetere V., Nagata S., Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 1995; 181: 781
   PubMed Web of Science ®Google Scholar
• Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., Nakao K., Nagata S. Expression of Fas ligand in cells of T cell lineage. J. Immunol. 1995; 154: 3806
   PubMed Web of Science ®Google Scholar
• Arase H., Arase N., Saito T. Fas-mediated cyto-toxicity by freshly isolated natural killer cells. J. Exp. Med. 1995; 181: 1235
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jerkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314
   PubMed Web of Science ®Google Scholar
• Allen R. D., Marshall J. D., Roths J. B., Sidman C. L. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 1990; 172: 1367
   PubMed Web of Science ®Google Scholar
• Takasaki T., Tanaka M., Brannan C. L, Jerkins N. A., Copeland N. G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969
   PubMed Web of Science ®Google Scholar
• Iwai K., Miyawaki T., Takizawa T., Konno A., Ohta K., Yachie A., Seki H., Taniguchi N. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994; 84: 1201
   PubMed Web of Science ®Google Scholar
• Matsumoto K., Schleimer R. P., Saito H., Likura Y., Bochner B. S. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995; 86: 1437
   PubMed Web of Science ®Google Scholar
• Taniguchi S., Shibuya T., Morioka E., Okamura T., Okamura S., Inaba S., Niho Y. Demonstration of three distinct immunological disorders on erythropoiesis in a patient with pure red cell aplasia and autoimmune haemolytic anaemia associated with thymoma. Br. J. Haematol. 1988; 68: 473
   PubMed Web of Science ®Google Scholar
• Kaegi D., Vignaux F., Ledermann B., Buerki K., Depraetere V., Nagata S., Hengartner H., Goldstein P. Fas and perform pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 1994; 265: 528
   PubMed Web of Science ®Google Scholar
• Kojima H., Shinohara N., Hanaoka S., Someya-Shirota Y., Takagaki Y., Ohno H., Saito T., Katayama T., Yagita H., Okumura K., Shinkai Y., Alt F. W., Matsuzawa A., Yonehara S., Takayama H. Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes. Cell 1994; 1: 357
   Google Scholar
• Lowin B., Hahne M., Mattmann C., Tschopp J. Cytotoxic T-cell cytotoxicity is mediated through perform and Fas lyric pathways. Nature 1994; 370: 650
   PubMed Web of Science ®Google Scholar
• Nagafuji K., Shibuya T., Harada M., Mizuno S., Takenaka K., Miyamoto T., Okamura T., Gondo H., Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995; 86: 883
   PubMed Web of Science ®Google Scholar
• Nagafuji K., Takenaka K., Shibuya T., Okamura T., Niho Y., Harada M. Ionizing radiation induces functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. 1996, Submitted
   Google Scholar
• Takenaka T., Nagafuji K., Harada M., Mizuno S., Miyamoto T., Makino S., Gondo H., Okamura T., Niho Y. In Vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood Revised. 1996
   Google Scholar
• Maciejewski J., Selleri C., Anderson S., Young N. S. Fas antigen expression on CD34+ human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995; 85: 3183
   PubMed Web of Science ®Google Scholar
• Moore M. A. S. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991; 78: 1
   PubMed Web of Science ®Google Scholar
• Perkins D. L., Michaelson J., Marshal-Rothstein A. The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice. J. Immunol. 1987; 138: 466
   PubMed Web of Science ®Google Scholar
• Ikehara S., Yasumizu R., Inaba M., Izui S., Hayakawa K., Sekita K., Toki J., Sugiura K., Iwai H., Nakamura T., Muso E., Hamashima Y., Good R. A. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. 1989; 86: 3306
   PubMed Web of Science ®Google Scholar
• Till J. E., McCulloch E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Rad. Research 1961; 14: 213
   PubMed Web of Science ®Google Scholar
• McCulloch E. A., Till J. E. The sensitivity of cells from normal mouse bone marrow to gamma radiation in vitro and in vivo. Rad. Research 1962; 16: 822
   PubMed Web of Science ®Google Scholar
• Senn J. S., McCulloch E. A. Radiation sensitivity of human bone marrow cells measured by a cell culture method. Blood 1970; 35: 56
   PubMed Web of Science ®Google Scholar
• Strasser A., Harris A. W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994; 79: 329
   PubMed Web of Science ®Google Scholar
• Spangrude G. J., Heimfeld S., Weissman I. L. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58
   PubMed Web of Science ®Google Scholar
• Hockenbery D., Zutter M., Hickey W., Nahm M., Korsmeyer S. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 1991; 88: 6961
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Bcl-2 initiates a new category of oncogenes: Regulation of cell death. Blood 1992; 80: 879
   PubMed Web of Science ®Google Scholar
• Domenico D., Aiello A., Soligo D., Fontanella E., Melani C., Pezzella F., Pierotti M. A., Porta G. D. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992; 79: 1291
   PubMed Web of Science ®Google Scholar
• Park J. R., Bernstein I. D., Hockenbery D. M. Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 1995; 86: 868
   PubMed Web of Science ®Google Scholar
• Singer G. G., Abbas A. K. The Fas Ag is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994; 1: 365
   PubMed Web of Science ®Google Scholar
• Yoshino T., Kondo E., Cao L., Takahashi K., Hayashi K., Nomura S., Akagi T. Inverse expression of bcl-2 protein and Fas Ag in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 1994; 83: 1856
   PubMed Web of Science ®Google Scholar
• Williams G. T., Smith C. A., Spooner E., Dextar T. M., Taylor D. R. Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76
   PubMed Web of Science ®Google Scholar
• Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806
   PubMed Web of Science ®Google Scholar
• Raza A., Gezer S., Mundle S., Gao X. Z., Alvi S., Borok R., Rifkin S., Iftikhar A., Shetty Y., Parcharidou A., Loew J., Marcus B., Khan Z., Channey C., Showel J., Gregory S., Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268
   PubMed Web of Science ®Google Scholar
• Sneller M. C., Straus S. E., Jaffe E. S., Jaffe J. S., Fleisher T. A., Steler-Stevenson M., Storber W. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J. Clin. Invest. 1992; 90: 334
   PubMed Web of Science ®Google Scholar
• Fisher G. H., Rosenberg F. J., Straus S. E., Dale J. K., Middelton L. A., Lin A. Y., Storber W., Lenardo M. J., Puck J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoprolifetative syndrome. Cell 1995; 81: 935
   PubMed Web of Science ®Google Scholar
• Rieux-Laucat F., Deist F. L., Hivroz C., Roberts I. A. G., Debatin K. M., Fischer A., de Vilartay J. P. Mutations in Fas associated with human lymphoprolifetative syndrome and autoimmunity. Science 1995; 268: 1347
   PubMed Web of Science ®Google Scholar